Catalyst
Recent Bullish bias from the Inverted Hammer signal on 20260211 points to potential upward momentum for CMS.
Most analysts rate CMS with a Buy, Strong Buy, or Neutral, indicating a generally optimistic institutional outlook.
Risk
Fund flows show an overall negative trend with large and extra-large orders indicating outflows, suggesting investor caution.
Fundamental negative factors such as elevated Asset-MV and Net income-Revenue ratios suggest potential valuation and profitability concerns.
Generated at21:4702/15/2026by
Aime